Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Note to USPTO Director Kappos

entire paragraph on re exams ending with

You can find the new http://www.uspto.gov/patents/Best_Practices_and_FAQs_for_filing_reexaminations_5_10_10.pdf">“Best Practices and FAQs for filing requests for reexamination compliant with 37 CFR 1.510 and 1.915” on the USPTO Web site. It covers the “general allegation” issue along with many others. We hope this document will assist parties who are preparing requests for reexamination and will facilitate initial processing of those requests at the USPTO.

As always, comments are welcome. Thanks for keeping them coming!

Share
New Message
Please login to post a reply